Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-17

FDA Approved: PHENTERMINE AND TOPIRAMATE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application to market a generic phentermine/topiramate combination for weight management in adults with obesity or overweight, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phentermine and topiramate (Phentermine and topiramate)

Snippet

SUPPL AP for PHENTERMINE AND TOPIRAMATE (PHENTERMINE AND TOPIRAMATE)